{"cik":"0001750149","ticker":"IKT","name":"Inhibikase Therapeutics, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-12","last_filing_date":"2026-08-11","url":"/sec/cik-0001750149","insider_summary":{"total_transactions":6,"unique_insiders":6,"latest_transaction":"2026-06-26"},"recent_filings":[{"accession_number":"0001193125-26-344775","form_type":"S-8","form_type_family":"other","doc_date":"2026-08-11","title":"S-8 — Inhibikase Therapeutics, Inc. — 2026-08-11","url_slug":"/sec/cik-0001750149/s-8/0001193125-26-344775","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-344775-index.html"},{"accession_number":"0001193125-26-344623","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-11","title":"8-K — Inhibikase Therapeutics, Inc. — 2026-08-11","url_slug":"/sec/cik-0001750149/8-k/0001193125-26-344623","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-344623-index.html"},{"accession_number":"0001193125-26-344707","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-11","title":"10-Q — Inhibikase Therapeutics, Inc. — 2026-08-11","url_slug":"/sec/cik-0001750149/10-q/0001193125-26-344707","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-344707-index.html"},{"accession_number":"0001193125-26-302580","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-14","title":"8-K — Inhibikase Therapeutics, Inc. — 2026-07-14","url_slug":"/sec/cik-0001750149/8-k/0001193125-26-302580","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-302580-index.html"},{"accession_number":"0001193125-26-290476","form_type":"4","form_type_family":"insider","doc_date":"2026-06-30","title":"4 — Inhibikase Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001750149/4/0001193125-26-290476","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-290476-index.html"},{"accession_number":"0001193125-26-290475","form_type":"4","form_type_family":"insider","doc_date":"2026-06-30","title":"4 — Inhibikase Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001750149/4/0001193125-26-290475","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-290475-index.html"},{"accession_number":"0001193125-26-290474","form_type":"4","form_type_family":"insider","doc_date":"2026-06-30","title":"4 — Inhibikase Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001750149/4/0001193125-26-290474","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-290474-index.html"},{"accession_number":"0001831942-26-000019","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Inhibikase Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001750149/schedule-13g-a/0001831942-26-000019","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001831942-26-000019-index.html"},{"accession_number":"0001493152-26-023791","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Inhibikase Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001750149/schedule-13g-a/0001493152-26-023791","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001493152-26-023791-index.html"},{"accession_number":"0001104659-26-062874","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — Inhibikase Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001750149/schedule-13g-a/0001104659-26-062874","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001104659-26-062874-index.html"},{"accession_number":"0001193125-26-219610","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-12","title":"8-K — Inhibikase Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001750149/8-k/0001193125-26-219610","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-219610-index.html"},{"accession_number":"0001193125-26-219641","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-12","title":"10-Q — Inhibikase Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001750149/10-q/0001193125-26-219641","edgar_url":"https://www.sec.gov/Archives/edgar/data/1750149/0001193125-26-219641-index.html"}],"related_endpoints":{"profile":"/sec/IKT/profile","timeline":"/sec/IKT/timeline","peers":"/sec/IKT/peers","insider_pulse":"/sec/IKT/insider-pulse","insider_summary":"/sec/IKT/insider-summary","insider_transactions":"/sec/IKT/insider-transactions","form144":"/sec/IKT/form144","holdings_as_filer":"/sec/IKT/holdings","financial_facts":"/sec/IKT/financial-facts","derivatives":"/sec/IKT/derivatives","officers":"/sec/IKT/officers","insider_network":"/sec/IKT/insider-network","risk_flags":"/sec/IKT/risk-flags","filings":"/sec/IKT/filings","cross_topic_dossier":"/api/v1/dossier?ticker=IKT"}}